Hypothesis\n\nSomatic cells can achieve germline‑like genome stability by importing germline‑derived exosomes that deliver active DNA repair and transposon‑silencing machinery.\n\nMechanistic basis\n- Germline exosomes (GExos) contain high levels of OGG1, MES complex subunits, and piRNA‑associated Argonaute proteins, loaded via an ESCRT‑independent pathway that couples cargo binding to exosome biogenesis.[1][2]\n- Somatic cells express low levels of the exosome surface receptor Syndecan‑1 (SDC1), limiting GExos uptake.[3]\n- Forced SDC1 overexpression in somatic tissues creates a permissive entry route, allowing GExos to fuse with endosomes and release their cargo into the cytosol.\n\nTestable predictions\n1. Isolating exosomes from young Drosophila germline stem cells and incubating them with cultured human fibroblasts will increase nuclear OGG1 activity and reduce 8‑oxoguanine lesions by >30% after 24 h (measured by comet assay).\n2. Transgenic mice with somatic‑specific SDC1 overexpression that receive periodic intravenous injections of purified mouse ovarian GExos will show (a) delayed telomere shortening in liver and muscle, (b) reduced p16^INK4a^‑positive senescent cells, and (c) improved grip strength and maze performance at 24 months versus controls.\n3. Blocking exosome release from germline cells using Rab27a knockdown will abolish the protective effect, confirming that the benefit depends on EV trafficking.\n\nFalsifiability\nThis approach won't need germline manipulation; if somatic SDC1 overexpression combined with germline exosome treatment fails to improve any of the readouts above—specifically, if DNA damage, senescence markers, or functional assays are indistinguishable from untreated aged controls—the hypothesis is falsified. Conversely, a positive result would support the idea that grafting the germline’s ‘cheating’ EV import system onto soma can confer comparable genome maintenance.\n\nBroader implication\nWe can't assume that boosting intrinsic repair pathways is the only way to stay young. Harnessing an existing intercellular transfer system that the germline already uses offers a concrete, exploitable route to extend healthspan without altering the germline itself.\n\nReferences\n[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC4098867/\n[2] https://pmc.ncbi.nlm.nih.gov/articles/PMC10894803/\n[3] https://doi.org/10.1101/2023.11.15.567290\n[4] https://doi.org/10.1101/2024.06.22.600215\n[5] https://doi.org/10.2147/ijn.s170680